3-131024591-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014065.4(ASTE1):c.716C>T(p.Ala239Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000093 in 1,612,406 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014065.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASTE1 | NM_014065.4 | c.716C>T | p.Ala239Val | missense_variant | 3/6 | ENST00000264992.8 | NP_054784.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASTE1 | ENST00000264992.8 | c.716C>T | p.Ala239Val | missense_variant | 3/6 | 1 | NM_014065.4 | ENSP00000264992 | P1 | |
ASTE1 | ENST00000514044.5 | c.716C>T | p.Ala239Val | missense_variant | 3/7 | 1 | ENSP00000426421 | |||
ASTE1 | ENST00000507978.5 | c.716C>T | p.Ala239Val | missense_variant, NMD_transcript_variant | 3/7 | 2 | ENSP00000421019 | |||
ASTE1 | ENST00000504964.1 | c.144-353C>T | intron_variant, NMD_transcript_variant | 3 | ENSP00000426363 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152110Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460296Hom.: 0 Cov.: 31 AF XY: 0.00000551 AC XY: 4AN XY: 726416
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152110Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74288
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at